| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0225U |
|
7,234 |
5,583 |
$2.27M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
8,880 |
7,181 |
$1.48M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
6,442 |
4,553 |
$849K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
10,992 |
8,603 |
$510K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,705 |
4,664 |
$417K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,737 |
15,825 |
$358K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,630 |
4,873 |
$226K |
| S9083 |
Global fee urgent care centers |
3,790 |
3,392 |
$175K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,917 |
7,853 |
$159K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,618 |
4,623 |
$121K |
| 99215 |
Prolong outpt/office vis |
3,640 |
3,430 |
$120K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,688 |
2,641 |
$118K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,336 |
3,830 |
$95K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,582 |
1,573 |
$87K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
3,248 |
2,837 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,186 |
3,137 |
$56K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,311 |
5,112 |
$46K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,286 |
1,021 |
$42K |
| 99205 |
Prolong outpt/office vis |
426 |
425 |
$24K |
| 99072 |
|
7,732 |
6,505 |
$22K |
| 81002 |
|
2,899 |
2,741 |
$6K |
| 0224U |
|
125 |
117 |
$4K |
| 81025 |
|
1,524 |
1,479 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
138 |
118 |
$1K |
| 93000 |
|
542 |
540 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
486 |
422 |
$935.45 |
| 0003A |
|
16 |
16 |
$640.00 |
| 0013A |
|
16 |
16 |
$600.00 |
| 99000 |
|
852 |
826 |
$503.10 |
| 36410 |
|
295 |
291 |
$480.47 |
| 99401 |
|
284 |
275 |
$388.19 |
| 0011A |
|
14 |
12 |
$380.00 |
| 82947 |
|
101 |
94 |
$219.27 |
| 81000 |
|
388 |
366 |
$200.89 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$170.34 |
| 85018 |
|
84 |
80 |
$115.92 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
27 |
27 |
$108.86 |
| 99402 |
|
35 |
34 |
$60.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
105 |
92 |
$54.87 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
40 |
40 |
$28.61 |
| 81003 |
|
45 |
45 |
$28.53 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$11.70 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
83 |
83 |
$10.59 |
| 36415 |
Collection of venous blood by venipuncture |
299 |
292 |
$3.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
13 |
13 |
$0.00 |
| 3074F |
|
29 |
29 |
$0.00 |
| 88150 |
|
26 |
26 |
$0.00 |
| 3078F |
|
17 |
17 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
16 |
$0.00 |